1433. Impact of 2019 US Food and Drug Administration (FDA) Guidance on Developing Drugs for Urinary Tract Infection (UTI) on the Perceived Efficacy of Antibiotics for the Treatment of Uncomplicated UTI (uUTI)

BACKGROUND: In 2019, the FDA issued guidance on drug development for treatment of UTIs. To explore the impact of this guidance, we compared clinical and microbiological outcomes of the fluoroquinolones norfloxacin and ciprofloxacin and the β-lactams pivmecillinam and sulopenem for treatment of uUTIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksen, Anne Santerre, Nicolle, Lindsay, Das, Anita F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644928/
http://dx.doi.org/10.1093/ofid/ofab466.1625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644928/
http://dx.doi.org/10.1093/ofid/ofab466.1625

Ejemplares similares